Choline

Choline

SCHEMBL7047847

C[N+](C)(C)CCO.O=P([O-])(O)O.Oc1c[nH]c2cc(Cl)ccc12

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3GNRHRMPLPDE3APDE3BPDE4APDE4BPDE4CPDE4DPPARASLC5A2

The experimentally established mechanism targets of Choline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.43
NR4A2 P43354 1/20 0.42
SLC6A4 P31645 1/20 0.38
ADRB3 P13945 1/20 0.38
ALDH1A1 P00352 1/20 0.35
HAT1 O14929 2/20 0.34
EP300 Q09472 2/20 0.34
AVPR1A P37288 2/20 0.33
PTGS1 P23219 1/20 0.33
PYGL P06737 1/20 0.33
F7 P08709 1/20 0.33
F3 P13726 1/20 0.33
NHERF1 O14745 2/20 0.32
IDO1 P14902 1/20 0.32
NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Choline SCHEMBL7045796 0.86 TDO2 (0.44) GPR84
Choline SCHEMBL1938782 0.83 POLB (0.42) GPR84NR4A2ALDH1A1
Choline SCHEMBL7041896 0.81 CSNK2A1 (0.38)
Phosphoric Acid SCHEMBL431773 0.80 GPR84 (0.54) GPR84NR4A2SLC6A4ALDH1A1PTGS1
Choline SCHEMBL7047866 0.79 NR4A2 (0.40) GPR84NR4A2SLC6A4IDO1
Choline SCHEMBL7041289 0.76 GPR84 (0.40) GPR84NR4A2SLC6A4ALDH1A1IDO1
SCHEMBL154688 0.76 GPR84 (0.63) GPR84NR4A2SLC6A4ALDH1A1F7
Choline SCHEMBL1938812 0.75
Acetic Acid SCHEMBL4223403 0.73 NR4A2 (0.55) GPR84NR4A2SLC6A4ALDH1A1AVPR1A
Choline SCHEMBL7044734 0.72 CYP3A4 (0.44) GPR84SLC6A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6660494-B2 Detecting phosphatidylcholine-specific phospholipase-C enzyme via incorporation of 3-indoxyl choline phosphate into substrate BIOSYNTH AG (CH) 2003-12-09 US disclosed
EP-1219628-B1 Novel substrates for detection of microbial metabolites BIOSYNTH AG (CH) 2003-04-02 EP disclosed
US-20020151725-A1 Detection of microbial metabolites BIOYNTH AG (CH) 2002-10-17 US disclosed
WO-2002051853-A1 DETECTION OF MICROBIAL METABOLITES BIOSYNTH AG (CH) 2002-07-04 WO disclosed
EP-1219628-A1 Novel substrates for detection of microbial metabolites Biosynth AG (CH) 2002-07-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020151725-A1 Detection of microbial metabolites LCT, CEL, PLCB1 GPR84 2820/4885NR4A2 3624/4885SLC6A4 1801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.